These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 19375041)

  • 41. Prompt arrival of antivirals against hepatitis C for HIV patients.
    Barreiro P; Vispo E
    AIDS Rev; 2010; 12(4):242-3. PubMed ID: 21344779
    [No Abstract]   [Full Text] [Related]  

  • 42. [ANRS HC 02 RIBAVIC: impact of steatosis in HIV-HCV co-infection].
    Pol S
    Gastroenterol Clin Biol; 2009 Mar; 33 Suppl 2():S110-2. PubMed ID: 19375038
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Co-infections. German doctors treat hepatitis C early, with some success.
    TreatmentUpdate; 2006; 18(5):3-4. PubMed ID: 17209229
    [No Abstract]   [Full Text] [Related]  

  • 44. Pegasys-Copegus combination treats both HIV and hepatitis C.
    AIDS Read; 2004 Apr; 14(4):164. PubMed ID: 15116695
    [No Abstract]   [Full Text] [Related]  

  • 45. [Acute hepatitis C virus infection--clinical manifestations, diagnosis and treatment].
    Peters L; Lindhardt BØ
    Ugeskr Laeger; 2006 Oct; 168(42):3601-4. PubMed ID: 17069720
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treating hepatitis C in patients with cirrhosis: the effort is worth it.
    Forns X; Bruix J
    J Hepatol; 2010 May; 52(5):624-6. PubMed ID: 20334945
    [No Abstract]   [Full Text] [Related]  

  • 47. Treatment of human papillomavirus with peg-interferon alfa-2b and ribavirin.
    Pavan MH; Velho PE; Vigani AG; Gonçalves FL; Aoki FH
    Braz J Infect Dis; 2007 Jun; 11(3):383-4. PubMed ID: 17684645
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Critical role of ribavirin for the achievement of early virological response to HCV therapy in HCV/HIV-coinfected patients.
    Ramos B; Núñez M; Rendón A; Berdún MA; Losada E; Santos I; Echevarría S; Ocampo A; Miralles C; Arazo P; Barreiro P; Romero M; Labarga P; Guardiola JM; Garcia-Samaniego J; Soriano V
    J Viral Hepat; 2007 Jun; 14(6):387-91. PubMed ID: 17501758
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting.
    ; ;
    Dig Liver Dis; 2010 Feb; 42(2):81-91. PubMed ID: 19748329
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Selection for treatment of hepatitis C co-infected patients for ].
    Findor J; Bessone F; Corti M
    Acta Gastroenterol Latinoam; 2006 Jun; 36 Suppl 1():S48-50; discussion S74-82. PubMed ID: 16862860
    [No Abstract]   [Full Text] [Related]  

  • 51. Predicting treatment outcome following 24 weeks peginterferon alpha-2a/ribavirin therapy in patients infected with HCV genotype 1: utility of HCV-RNA at day 0, day 22, day 29, and week 6.
    Lukasiewicz E; Hellstrand K; Westin J; Ferrari C; Neumann AU; Pawlotsky JM; Schalm SW; Zeuzem S; Veldt BJ; Hansen BE; Verhey-Hart E; Lagging M
    Hepatology; 2007 Jan; 45(1):258-9. PubMed ID: 17187414
    [No Abstract]   [Full Text] [Related]  

  • 52. Second thoughts about secondary analyses.
    Ferenci P
    Dig Liver Dis; 2005 Oct; 37(10):805-7; author reply 808-9. PubMed ID: 16023903
    [No Abstract]   [Full Text] [Related]  

  • 53. Comment on Neumann et al. 'Differential antiviral effect of PEG-interferon-alpha-2b on HIV and HCV in the treatment of HIV/HCV co-infected patients'.
    D'Offizi G; Martini F; Rozera G; Abbate I; Capobianchi MR; Narciso P; Dianzani F
    AIDS; 2008 Jan; 22(2):321. PubMed ID: 18097242
    [No Abstract]   [Full Text] [Related]  

  • 54. Acute hepatitis C and HIV coinfection.
    Dionne-Odom J; Osborn MK; Radziewicz H; Grakoui A; Workowski K
    Lancet Infect Dis; 2009 Dec; 9(12):775-83. PubMed ID: 19926037
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Long-acting interferon: studies on pegylated interferon].
    Ma H; Wang H
    Zhonghua Gan Zang Bing Za Zhi; 2002 Feb; 10(1):78-9. PubMed ID: 11856520
    [No Abstract]   [Full Text] [Related]  

  • 56. Peginterferon alfa-2b and ribavirin in thalassaemia/chronic hepatitis C virus-co-infected non-responder to standard interferon-based.
    Hamidah A; Thambidorai CR; Jamal R
    Med J Malaysia; 2005 Oct; 60(4):517-9. PubMed ID: 16570722
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Study results presented on interferon/ribavirin combination therapy.
    AIDS Read; 2001 Aug; 11(8):398. PubMed ID: 11570262
    [No Abstract]   [Full Text] [Related]  

  • 58. Hepatitis C virus in the setting of HIV or hepatitis B virus coinfection.
    Sterling RK; Sulkowski MS
    Semin Liver Dis; 2004; 24 Suppl 2():61-8. PubMed ID: 15346248
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatitis C treatment, HAART and side effects.
    TreatmentUpdate; 2001; 13(7):7-8. PubMed ID: 11794865
    [No Abstract]   [Full Text] [Related]  

  • 60. Acquired factor VIII inhibitor in an HIV-infected patient after treatment with pegylated interferon-alpha 2a and ribavirin.
    Paul S; Javed U; Tevendale R; Lanford J; Liu R
    AIDS; 2007 Mar; 21(6):784-5. PubMed ID: 17413709
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.